Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00573
|
|||||
| Drug Name |
Elacridar
|
|||||
| Synonyms |
143851-98-3; 4CA-0489; 7066AA; AC-30266; AC1L55DX; AC1Q3EOG; ACN-041487; AKOS016005297; AOB5938; BCP14056; C34H34ClN3O5; CHEMBL2074730; CS-1113; D03968; Elacridar (hydrochloride); Elacridar HCl; Elacridar hydrochloride; Elacridar hydrochloride (USAN); Elacridar hydrochloride [USAN]; FT-0696337; GF 120918; GF-120918A; HY-50880; MolPort-023-332-877; N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide hydro; NX2BHH1A5B; SCHEMBL15847793; UNII-NX2BHH1A5B; W-5457; gf 120918a
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C34H34ClN3O5
|
|||||
| Canonical SMILES |
COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC.Cl
|
|||||
| InChI |
InChI=1S/C34H33N3O5.ClH/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37;/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38);1H
|
|||||
| InChIKey |
IQOJZZHRYSSFJM-UHFFFAOYSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 600.1 | Topological Polar Surface Area | 89.1 | ||
| Heavy Atom Count | 43 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 7 | |||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.